187 related articles for article (PubMed ID: 29753463)
1. De Novo Urologic Malignancies in Renal Transplant Recipients.
Antunes H; Tavares-da-Silva E; Oliveira R; Carvalho J; Parada B; Bastos C; Figueiredo A
Transplant Proc; 2018 Jun; 50(5):1348-1354. PubMed ID: 29753463
[TBL] [Abstract][Full Text] [Related]
2. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
3. Development of urologic de novo malignancies after renal transplantation.
Hevia V; Gómez V; Díez Nicolás V; Alvarez S; Gómez Del Cañizo C; Galeano C; Gomis A; García-Sagredo JM; Marcen R; Burgos FJ
Transplant Proc; 2014; 46(1):170-5. PubMed ID: 24507046
[TBL] [Abstract][Full Text] [Related]
4. [De novo urologic tumors in kidney transplant patients].
Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
[TBL] [Abstract][Full Text] [Related]
6. Urologic de novo malignancies after kidney transplantation: a single center experience.
Karczewski M; Czapiewski W; Karczewski J
Transplant Proc; 2012 Jun; 44(5):1293-7. PubMed ID: 22664003
[TBL] [Abstract][Full Text] [Related]
7. Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center.
Tsaur I; Karalis A; Probst M; Blaheta RA; Scheuermann EH; Gossmann J; Kachel HG; Hauser IA; Jonas D; Obermüller N
Cancer Sci; 2010 Nov; 101(11):2430-5. PubMed ID: 20707803
[TBL] [Abstract][Full Text] [Related]
8. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
9. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
10. Transitional cell carcinoma of the urinary tract in renal transplant recipients.
Husain E; Khawaja A; Shaikh T; Yaqoob M; Junaid I; Baithun S
Pathology; 2009; 41(4):406-8. PubMed ID: 19404862
[No Abstract] [Full Text] [Related]
11. Transitional cell carcinoma in renal transplant recipients: a single center experience.
Li XB; Xing NZ; Wang Y; Hu XP; Yin H; Zhang XD
Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
[TBL] [Abstract][Full Text] [Related]
12. De Novo Cancer Incidence and Prognosis After Kidney Transplantation: A Single Center Analysis.
Gioco R; Corona D; Agodi A; Privitera F; Barchitta M; Giaquinta A; Alba I; D'Errico S; Pinto F; De Pasquale C; Pistorio ML; Veroux P; Veroux M
Transplant Proc; 2019 Nov; 51(9):2927-2930. PubMed ID: 31607617
[TBL] [Abstract][Full Text] [Related]
13. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
[TBL] [Abstract][Full Text] [Related]
14. De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
Yuan M; Shi YB; Li ZH; Xia M; Ji GZ; Xu GX; Han Y
Transplant Proc; 2009 Jun; 41(5):1619-23. PubMed ID: 19545692
[TBL] [Abstract][Full Text] [Related]
15. Urological tumors in renal transplantation.
Tillou X; Doerfler A
Minerva Urol Nefrol; 2014 Mar; 66(1):57-67. PubMed ID: 24721941
[TBL] [Abstract][Full Text] [Related]
16. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
Kim DY; Abouljoud M; Parasuraman R
Transplant Proc; 2010 Jun; 42(5):1641-2. PubMed ID: 20620491
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of kidney transplant tourism and risk factors for de novo urothelial carcinoma.
Tsai HL; Chang JW; Wu TH; King KL; Yang LY; Chan YJ; Yang AH; Chang FP; Pan CC; Yang WC; Loong CC
Transplantation; 2014 Jul; 98(1):79-87. PubMed ID: 24879380
[TBL] [Abstract][Full Text] [Related]
18. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study.
Lu K; Chiu KY
Clin Transplant; 2023 Oct; 37(10):e15047. PubMed ID: 37306943
[TBL] [Abstract][Full Text] [Related]
19. Renal transplantation across the donor-specific antibody barrier: Graft outcome and cancer risk after desensitization therapy.
Yang CY; Lee CY; Yeh CC; Tsai MK
J Formos Med Assoc; 2016 Jun; 115(6):426-33. PubMed ID: 26725772
[TBL] [Abstract][Full Text] [Related]
20. De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years.
Zavos G; Moris D; Kostakis ID; Vernadakis S; Bokos J; Zavvos V; Lionaki S; Boletis J
Exp Clin Transplant; 2015 Aug; 13(4):313-8. PubMed ID: 26295181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
